Back to search

Article

ELABELA as a Potential Diagnostic Biomarker and Therapeutic Target of Atherosclerosis

2024-11-08

Abstract excerpt

Atherosclerosis (AS) is a progressive arterial disease characterized by chronic inflammation and plaque formation in blood vessel walls. ELABELA, an endogenous ligand for the G protein-coupled receptor APJ (apelin peptide jejunum, apelin receptor), has multiple pharmacological activities for protecting the cardiovascular system. This study aimed to determine the potential anti-atherosclerotic effect of ELABELA and...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f7ac465c-42ac-5230-b74c-5d24bebb3e9e
DOI
10.1101/2024.11.07.24316940
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
ELABELA as a Potential Diagnostic Biomarker and Therapeutic Target of AtherosclerosisDOI 10.1101/2024.11.07.24316940
Select a neighboring publication to make it the new centre.